Vertex Pharmaceuticals Incorporated shares owned by Calamos Advisors
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Calamos Advisors
from 13F filings
Historical chart of Calamos Advisors investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Calamos Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Calamos Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $18M | 46k | 391.64 |
| 2025-06-30 | $20M | 46k | 445.20 |
| 2025-03-31 | $22M | 46k | 484.82 |
| 2024-12-31 | $18M | 45k | 402.70 |
| 2024-09-30 | $21M | 45k | 465.08 |
| 2024-06-30 | $22M | 46k | 468.72 |
| 2024-03-31 | $20M | 48k | 418.01 |
| 2023-12-31 | $28M | 69k | 406.89 |
| 2023-09-30 | $24M | 70k | 347.74 |
| 2023-06-30 | $25M | 70k | 351.91 |
| 2023-03-31 | $26M | 82k | 315.07 |
| 2022-12-31 | $27M | 92k | 288.78 |
| 2022-09-30 | $31M | 108k | 289.54 |
| 2022-06-30 | $30M | 108k | 281.79 |
| 2022-03-31 | $27M | 105k | 260.97 |
| 2021-12-31 | $20M | 91k | 219.61 |
| 2021-09-30 | $20M | 111k | 181.39 |
| 2021-06-30 | $26M | 128k | 201.63 |
| 2021-03-31 | $43M | 199k | 214.89 |
| 2020-12-31 | $34M | 142k | 236.34 |
| 2020-09-30 | $40M | 146k | 272.12 |
| 2020-06-30 | $50M | 172k | 290.31 |
| 2020-03-31 | $27M | 115k | 237.95 |
| 2019-12-31 | $9.1M | 42k | 218.96 |
| 2019-09-30 | $7.2M | 43k | 169.41 |
| 2019-06-30 | $7.1M | 39k | 183.38 |
| 2019-03-31 | $6.8M | 37k | 183.94 |
| 2018-12-31 | $6.0M | 36k | 165.72 |
| 2018-09-30 | $6.0M | 31k | 192.74 |
| 2018-06-30 | $5.8M | 34k | 169.95 |
| 2018-03-31 | $4.9M | 30k | 162.99 |
| 2017-12-31 | $4.3M | 29k | 149.85 |
| 2017-09-30 | $4.4M | 29k | 152.04 |
| 2017-06-30 | $3.6M | 28k | 128.87 |
| 2013-12-31 | $3.2M | 43k | 74.30 |
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated